Found 9 matching trials
Ritlecitinib for Cicatricial Alopecia
PHASE2Alopecia could be subdivided into two main groups of diseases: non-scarring...
Location
Icahn School of Medicine at Mount Sinai
Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide
PHASE1This is a Phase 1, 2-period, multiple-dose, open-label, single fixed sequen...
Location
New Haven Clinical Research Unit
A Target Occupancy Study With Ritlecitinib.
PHASE1This is a phase 1, open label, two-arm study to assess target occupancy and...
Location
Pfizer Clinical Research Unit - New Haven
Long-Term PF-06651600 for the Treatment of Alopecia Areata
PHASE3This is a global Phase 3 study to evaluate the safety and effectiveness of ...
Location
The University of Alabama at Birmingham Hosptial Outreach Lab
Estimation of the Effect of Multiple Dose Ritlecitinib (PF-06651600) on the Pharmacokinetics of a Single Dose of Caffeine in Healthy Participants
PHASE1This will be a Phase 1, 2 period, fixed sequence, multiple-dose, open-label...
Location
New Haven Clinical Research Unit
PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATA
PHASE2This is a global Phase 2a randomized, double-blind, placebo-controlled stud...
Location
Marvel Clinical Research 002, LLC
A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo
PHASE3A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents wit...
Location
University of Alabama at Birmingham
Ritlecitinib in CTCL
PHASE2The purpose of this research study is to evaluate the effectiveness and saf...
Location
Icahn School of Medicine at Mount Sinai
Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)
PHASE2A multi-center, placebo-controlled, double blind, 1:1:1 randomized control ...
Status
Active Not Recruiting
Location
Children's Hospital Orange County